Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Weitan Pharmaceutical Technology is a specialized pharmaceutical service provider based in Hangzhou, China. The company focuses on the research, development, and production of high-quality pharmaceutical impurities, reference standards, and isotope-labeled compounds. They offer comprehensive Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) services, including custom synthesis and process optimization for small molecule drugs. Weitan Pharma supports global pharmaceutical companies and research institutions by providing critical analytical standards and chemical intermediates required for drug development and regulatory compliance. Their expertise extends to the synthesis of complex metabolites and degradation products used in quality control and safety assessment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Weitan Pharmaceutical Technology.